Evaluation of the Dwell-Time and Dose Difference in Intravesical Bacillus Calmette-Guèrin Therapy

OBJECTIVE: Bacillus Calmette-Guèrin (BCG) intravesical therapy is currently established using a low dose because of the high incidence of side-effects. Moreover, shortening the dwell time of BCG is conducted in some facilities owing to the complications associated with a long dwell time after inject...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagai, Takashi, Okamura, Takehiko, Tanaka, Yutaro, Moritoki, Yoshinobu, Kobayashi, Daichi, Kobayashi, Takahiro, Akita, Hidetoshi, Yasui, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857891/
https://www.ncbi.nlm.nih.gov/pubmed/31127897
http://dx.doi.org/10.31557/APJCP.2019.20.5.1389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857891/
https://www.ncbi.nlm.nih.gov/pubmed/31127897
http://dx.doi.org/10.31557/APJCP.2019.20.5.1389

Ejemplares similares